Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features (Q38138170)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

author name string

Peter Kristian Rasmussen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

91 Thesis 5

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1-27

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Immune defense at the ocular surface

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

A Danish population-based analysis of 105 mantle cell lymphoma patients: incidences, clinical features, response, survival and prognostic factors

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Graves' ophthalmopathy

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

AIDS-associated non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Curative radiotherapy for primary orbital lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The human intestinal immune system: basic cellular and humoral mechanisms

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Pathogenesis of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The conjunctival lymphoid follicle in mucosal immunology

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations?

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Orbital lymphatics: do they exist?

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differences.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Intestinal IgA synthesis: regulation of front-line body defences

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphoproliferative lesions of the lacrimal gland: clinicopathological, immunohistochemical and molecular genetic analysis

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphoma of the ocular adnexa: A study of 353 cases

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Role of lactoferrin in the tear film.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Positron emission tomography/computed tomography surveillance in patients with lymphoma: a fox hunt?

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Roles of human beta-defensins in innate immune defense at the ocular surface: arming and alarming corneal and conjunctival epithelial cells

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Front-line treatment of mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC autologous stem-cell support: still very long survival but late relapses do occur.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Cell of origin fails to predict survival in patients with diffuse large B‐cell lymphoma treated with autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lacrimal gland lesions in Denmark between 1974 and 2007

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphomatous proptosis as a novel feature of mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Clinical features associated with survival of patients with lymphoma of the ocular adnexa

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

miRNAs and apoptosis: RNAs to die for.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Does immunohistochemistry allow easy detection of lymphatics in the optic nerve sheath?

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Antigenic profile of the human lacrimal gland

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The role of eye-associated lymphoid tissue in corneal immune protection

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Local production of secretory IgA in the eye-associated lymphoid tissue (EALT) of the normal human ocular surface

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Primary salivary gland lymphoma among Japanese: A clinicopathological study of 30 cases

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Aggressive lymphomas

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Stromal gene signatures in large-B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type of the ocular adnexa: retrospective single institution review of 95 patients

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Mantle cell lymphoma in the ocular adnexal region

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Molecular pathogenesis of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Ocular adnexal diffuse large B-cell lymphoma: local disease correlates with better outcomes

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Defensins and other antimicrobial peptides at the ocular surface

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Normal tear protein profiles and age-related changes

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The ocular humoral immune response in health and disease

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphocyte trafficking across high endothelial venules: dogmas and enigmas

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphoma dissemination: the other face of lymphocyte homing

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Malignant lymphoproliferative disorders extending into the orbit from the paranasal sinuses

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Mantle cell lymphoma in the orbital and adnexal region

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1).

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The role of FDG-PET scans in patients with lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Rituximab (Rituxan).

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Diffuse large B-cell lymphoma of the orbit: clinicopathologic, immunohistochemical, and prognostic features of 20 cases.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The biology of human lymphoid malignancies revealed by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Extranodal marginal zone lymphoma of the ocular adnexa

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Lymphoproliferation in autoimmunity and Sjögren’s syndrome

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratification

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20 B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Localized Orbital Mucosa-Associated Lymphoma Tissue Lymphoma Managed With Primary Radiation Therapy: Efficacy and Toxicity

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Epidemiology of lymphomas

1 reference

https://api.crossref.org/works/10.1111/AOS.12189

21 January 2018

Identifiers

10.1111/AOS.12189

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38138170&oldid=1743393718"